Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers DOI
David S. Mathai,

Samantha Hilbert,

Nathan D. Sepeda

et al.

Psychedelic Medicine, Journal Year: 2023, Volume and Issue: 1(4), P. 241 - 252

Published: Aug. 30, 2023

N-methyl-D-aspartate receptor-mediated dissociatives and serotonergic hallucinogens are being increasingly used in therapeutic interventions that involve nonordinary states of consciousness may represent a unique mental health paradigm wherein pharmacologically induced experiences conducive to psychological well-being.The aim this study was further understand how the phenomenological health-promoting effects high-dose dextromethorphan (DXM) compared psilocybin same participants when administered under experimental conditions typical psychedelic trials.Single, acute oral doses DXM (400 mg/70 kg), (10, 20, 30 inactive placebo were double-blind psychologically supportive 20 healthy with histories hallucinogen use. Ratings personal meaning, spiritual significance, challenge, insight attributed drug assessed 7 h (at session end) 1 week after each administration. Persisting administration.High-dose produced similar increases over ratings experience predictive benefit at week, even expectancy minimized. These tended favor dose-dependent manner limited by poor physical tolerability for DXM.This analysis suggests utility exploring clinical applications occur within contexts characteristic research prioritize optimization valuable experiences. This registered ClinicalTrials.gov (NCT02033707).

Language: Английский

The antidepressant actions of ketamine and its enantiomers DOI
Jenessa N. Johnston, Ioline D. Henter, Carlos A. Zarate

et al.

Pharmacology & Therapeutics, Journal Year: 2023, Volume and Issue: 246, P. 108431 - 108431

Published: May 4, 2023

Language: Английский

Citations

72

Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics? DOI Creative Commons
Kenji Hashimoto

European Archives of Psychiatry and Clinical Neuroscience, Journal Year: 2024, Volume and Issue: unknown

Published: Feb. 27, 2024

The growing interest in the rapid and sustained antidepressant effects of dissociative anesthetic ketamine classic psychedelics, such as psilocybin, is remarkable. However, both psychedelics are known to induce acute mystical experiences; can cause symptoms out-of-body experience, while typically bring about hallucinogenic experiences, like a profound sense unity with universe or nature. role these experiences enhancing outcomes for patients depression currently an area ongoing investigation debate. Clinical studies have shown that following administration (S)-ketamine (esketamine) not directly linked their properties. In contrast, potential (R)-ketamine (arketamine), thought lack side effects, has yet be conclusively proven large-scale clinical trials. Moreover, although activation serotonin 5-HT

Language: Английский

Citations

29

Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential DOI
Josh Allen, Shannon Dames, Claire J. Foldi

et al.

Molecular Psychiatry, Journal Year: 2024, Volume and Issue: 29(3), P. 671 - 685

Published: Jan. 4, 2024

Language: Английский

Citations

13

The mechanistic divide in psychedelic neuroscience: An unbridgeable gap? DOI Creative Commons

Bryan Barksdale,

Manoj K. Doss, Gregory A. Fonzo

et al.

Neurotherapeutics, Journal Year: 2024, Volume and Issue: unknown, P. e00322 - e00322

Published: Jan. 1, 2024

In recent years, psychedelics have generated considerable excitement and interest as potential novel therapeutics for an array of conditions, with the most advanced evidence base in treatment certain severe and/or treatment-resistant psychiatric disorders. An clinical pre-clinical has informed our current understanding how produce profound alterations consciousness. Mechanisms psychedelic action include receptor binding downstream cellular transcriptional pathways, long-term impacts on brain structure function—from level single neurons to large-scale circuits. this perspective, we first briefly review synthesize separate lines research mechanistic processes underlying acute effects compounds, a particular emphasis highlighting theoretical models drug their relationships therapeutic benefits brain-based We then highlight existing area ongoing controversy argue is directly by originating from disparate levels inquiry, ultimately converge notion that bridging chasm explanatory across inquiry (molecular, cellular, circuit, psychological/behavioral) through innovative methods collaborative efforts will yield comprehensive needed fully capitalize properties these compounds.

Language: Английский

Citations

13

Exploring DMT: Endogenous Role and Therapeutic Potential DOI Creative Commons
J. Schimmelpfennig, Kamila Jankowiak-Siuda

Neuropharmacology, Journal Year: 2025, Volume and Issue: unknown, P. 110314 - 110314

Published: Jan. 1, 2025

Language: Английский

Citations

1

From helplessness to controllability: toward a neuroscience of resilience DOI Creative Commons
Michael V. Baratta, Martin E. P. Seligman, Steven F. Maier

et al.

Frontiers in Psychiatry, Journal Year: 2023, Volume and Issue: 14

Published: May 3, 2023

“Learned helplessness” refers to debilitating outcomes, such as passivity and increased fear, that follow an uncontrollable adverse event, but do not when event is controllable. The original explanation argued events are the animal learns outcomes independent of its behavior, this active ingredient in producing effects. Controllable events, contrast, fail produce these because they lack uncontrollability element. Recent work on neural basis helplessness, however, takes opposite view. Prolonged exposure aversive stimulation per se produces debilitation by potent activation serotonergic neurons brainstem dorsal raphe nucleus. Debilitation prevented with instrumental controlling response, which activates prefrontal circuitry detecting control subsequently blunting nucleus response. Furthermore, learning alters response future thereby preventing long-term resiliency. general implications neuroscience findings may apply psychological therapy prevention, particular suggesting importance cognitions control, rather than habits control.

Language: Английский

Citations

18

At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data DOI Creative Commons
David S. Mathai, Thomas D. Hull,

Leonardo Vando

et al.

Journal of Affective Disorders, Journal Year: 2024, Volume and Issue: 361, P. 198 - 208

Published: May 27, 2024

Improving safe and effective access to ketamine therapy is of high priority given the growing burden mental illness. Telehealth-supported administration sublingual being explored toward this goal. In longitudinal study, moderately-to-severely depressed patients received four doses at home over weeks within a supportive digital health context. Treatment was structured resemble methods therapeutic psychedelic trials. Patients receiving second course treatment were also examined. Symptoms assessed using Patient Health Questionnaire (PHQ-9) for depression. We conducted preregistered machine learning symptom network analyses investigate outcomes (osf.io/v2rpx). A sample 11,441 analyzed, demonstrating modal antidepressant response from both non-severe (n = 6384, 55.8 %) severe 2070, 18.1 baseline depression levels. Adverse events detected in 3.0–4.8 % participants predominantly neurologic or psychiatric nature. helped extend improvements who responded favorably initial treatment. Improvement most strongly predicted by lower scores age baseline. Depressed mood Anhedonia sustained despite ongoing This study limited absence comparison control groups lack fixed-dose procedure administration. At-home, telehealth-supported largely safe, well-tolerated, associated with improvement Strategies combining psychedelic-oriented therapies rigorous telehealth models, as here, may uniquely address barriers

Language: Английский

Citations

6

Disease diagnosis and application analysis of molecularly imprinted polymers (MIPs) in saliva detection DOI
Yanan Li, Changjun Guan, Chaoran Liu

et al.

Talanta, Journal Year: 2023, Volume and Issue: 269, P. 125394 - 125394

Published: Nov. 6, 2023

Language: Английский

Citations

14

Long-term follow-up of participants in ketamine clinical trials for mood disorders DOI

Kelly T. Hurst,

Abigail Vogeley,

Deanna Greenstein

et al.

Journal of Affective Disorders, Journal Year: 2024, Volume and Issue: 357, P. 134 - 137

Published: April 22, 2024

Language: Английский

Citations

5

Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy DOI
P. Baldinger, Marie Spies, Ina Bozic

et al.

Wiener klinische Wochenschrift, Journal Year: 2024, Volume and Issue: unknown

Published: April 17, 2024

Language: Английский

Citations

4